Prothena (PRTA) Company Long-Term Loans and Borrowings

prothena.com - graphic logo of issuer PRTA

The price chart for Prothena Corporation (PRTA) illustrates the dynamics of long-term liabilities, which currently stand at 0.00. The company is implementing sustainable development principles by reducing water consumption and minimizing laboratory waste. Its activities in developing neurodegeneration therapies are not subject to GDP fluctuations or seasonality. As the company is currently in the testing phase, its future revenues will depend on patent protection and drug efficacy.

PRTA (Prothena) Company Long-Term Debt history from 07/04/2022 to 10/29/2026

Financial and market metric breakdowns for prothena.com (PRTA)

- price and consensus price forecast:
Stock Price Prothena Biosciences|PRTA - Price Target Chart
- market capitalization data:
Market Value Prothena|PRTA - Total Company Value
- book capitalization data:
Net Asset Value per Share Prothena|PRTA - Company Book Value|Market Capitalization to Net Assets prothena.com|PRTA - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Prothena Corporation|PRTA - Long-Term Debt to Equity|Current Liabilities to Capital Prothena|PRTA - Company Total Debt|Debt to Book Capital Prothena|PRTA - Company Long-Term Debts|Company Short-Term Loans and Borrowings Prothena
Fundamental company analysis:PRTA (Prothena Corporation PLC)
Manufactured products of Prothena Corp

This indicator tracks total liabilities with a maturity of more than one year, determining the issuer's level of financial stability. Investors analyze this metric to assess the business's ability to service loans without compromising operational activities. By examining the company's long-term debt structure, one can evaluate the risks of underfunding costly clinical trials. This is critical for Prothena Corporation (PRTA), as production robotization does not replace the mandatory labor costs for physician compensation.

Analysis of competing companies

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACAD (ACADIA Corp) - Long-Term Debt|Company Long-Term Debt Xenon Pharmaceuticals XENE|Long-Term Liabilities VKTX|Supernus (SUPN) - Company Long-Term Debt|Company Long-Term Loans and Borrowings CPRX (Catalyst Pharma)|DNLI: Company Long-Term Debt|HRMY - Long-Term Debt|Company Long-Term Liabilities Biohaven Ltd. BHVN|AMLX - Amount of Long-Term Liabilities|Company Long-Term Debts Trevi Therapeutics, Inc. TRVI|Praxis Precision Medicines Inc (PRAX) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AVXL (Anavex Corp)|Long-Term Debt CBLL|Company Long-Term Debt Alector, Inc. ALEC|Company Long-Term Indebtedness annexonbio.com (ANNX)|Company Long-Term Debts OMER (Omeros)|NGNE - Company Long-Term Debts|Company Long-Term Liabilities AC Immune Corp (ACIU)|VYGR - Company Long-Term Loans and Borrowings|NMRA (Neumora Therapeutics) - Company Long-Term Debts|SCLX (scilexholding.com) - Company Long-Term Liabilities|Company Long-Term Debt TVGN (Tevogen Bio)|Long-Term Debt ACOG|Cognition Therapeutics (CGTX) - Company Long-Term Debt|Company Long-Term Loans and Borrowings IKT (Inhibikase Pharma)|Cassava Sciences, Inc. (SAVA) - Company Long-Term Debt|Assertio Holdings - Long-Term Liabilities|COYA (Coya) - Company Long-Term Debt|VTGN: Long-Term Debt|Company Long-Term Debt ovidrx.com OVID|Acumen Pharmaceuticals, Inc (ABOS) - Company Long-Term Loans and Borrowings|CRVO (CervoMed Inc.) - Company Long-Term Debts|Company Long-Term Debts Alterity Therapeutics Ltd (ATHE)|Company Long-Term Liabilities Clene Inc.|Amount of Long-Term Liabilities pepgen.com (PEPG)|Company Long-Term Debts JUNS|Relmada Corp - Long-Term Debt Volume|ANVS (Annovis Bio, Inc.) - Company Long-Term Debt|GRCE: Long-Term Debt|Company Long-Term Debt Firefly Neuroscience|KLTO (Klotho Neurosciences) - Company Long-Term Indebtedness|Company Long-Term Debt NeuroSense Therapeutics Ltd NRSN|Long-Term Liabilities RVPH|MetaVia Inc (MTVA) - Company Long-Term Debt|Company Long-Term Loans and Borrowings neuraxis.com NRXS|Company Long-Term Liabilities Helius Medical Technologies (HSDT)|Amount of Long-Term Liabilities Passage Bio Inc. PASG|Neuphoria - Company Long-Term Debts|NERV: Company Long-Term Debts|Company Long-Term Debt Athira Pharma, Inc.|addextherapeutics.com (ADXN) - Company Long-Term Indebtedness|Company Long-Term Debts ALZN (Alzamend Neuro Inc.)|Long-Term Debt Cyclerion (CYCN)|Company Long-Term Liabilities PTIX|Company Long-Term Debts KTTA (pasitheaclinics.com)|Company Long-Term Debt Cortigent|avenuetx.com - Company Long-Term Loans and Borrowings|BCLI (BrainStorm Cell Therapeutics) - Company Long-Term Debt|CARA: Long-Term Debt|Company Long-Term Debt Chromocell Therapeutics Corporation (CHRO)|ELYM (Eliem Therapeutics Inc.) - Long-Term Liabilities|ITCI - Company Long-Term Debt|Company Long-Term Loans and Borrowings LBPH|Marinus Pharmaceuticals, Inc. - Company Long-Term Debt|Long-Term Debt NKGen Biotech Inc NKGN|Company Long-Term Liabilities NeuroBo (NRBO)|Amount of Long-Term Liabilities Sage Therapeutics Inc SAGE|Company Long-Term Debts Synaptogenix, Inc. (SNPX)|TRVN - Company Long-Term Loans and Borrowings|Company Long-Term Debts VIGL|WENA (Anew Medical Inc.) - Long-Term Debt|Company Long-Term Debt Cerevel (CERE)